New research has shown that 1 in 10 men experience erectile dysfunction (ED) and as many as 1 in 5 men suffer a loss of libido, as a result of work-related stress.
These latest figures suggest that 90% of men have shown at least one clinical feature of stress due to work but only 54% of men know that stress from work may be the cause of their ED. Stress, either at work or home, is a known cause of ED and prolonged stress is associated with low testosterone levels.
Unfortunately 44% of men would not go to their GP if they experience erection problems, and those who do go to their GP about their ED wait on average 17 months before going for a consultation. But there’s no need to delay - oral treatments for ED (PDE5 inhibitors), such as Levitra, Viagra and Cialis, have revolutionised the treatment of men with ED and are now widely prescribed as a first option for treatment.
Dr David Edwards, an Oxfordshire GP comments: “Work-place stress clearly has a strong impact on the incidence of ED in men. Men should think about the underlying cause of their ED, including how to combat their stress levels; not staying too late at work, a balanced and healthy diet, and regular exercise. We know that oral treatments usually work well for men with ED, but 1 in 3 men with ED are not able to have satisfactory sex the first time they take a tablet and consequently a third of them do not return to their doctor. These men could still be successfully treated by simply switching to a different tablet or increasing the dose, and should be encouraged to return to their GP.”
Men have recently ranked ‘high success rate with first tablet’ as one of the most desirable attributes that a treatment can have. It is important for men with ED not to give up on their treatment too soon and return to their GP to ensure that they have tried the range of treatments available.
Low testosterone levels (which may be stress-related) can cause ED and also prevent PDE5 inhibitors working properly. All men with ED should ask their GP to test their testosterone levels. If low, this can be treated successfully alongside treatments for ED.
The SortED in 10 Campaign supported the research and highlighted that erection problems are very common, affecting half of all men between the age of 40 and 70. Given the range of oral treatments now available men should waste no time in asking their GP or nurse about what help is available. For further information about ED visit www.sortEDin10.co.uk.
- Ends -
Notes to Editors:
•ED is defined as the inability of a man to achieve or maintain an erection that is sufficient for sexual performance. It is also sometimes referred to as ‘erection difficulties’ or ‘impotence’
•Between the age of 40 and 70, more than 50% of men will experience some form of ED
•Despite its prevalence, it is estimated that only 10% of ED sufferers are being treated
•Not only does ED have a devastating affect on men’s self-esteem, it can also be a marker for more serious underlying disease such as heart disease and diabetes8
•For further information about ED, please visit: www.sortEDin10.co.uk
About the Research
The research was conducted by ICM Research amongst 983 UK men between the ages of 18 and 70.
About SortED in 10
SortED in 10 is a national men’s health campaign launched in 2005 and sponsored by Bayer Schering Pharma. The campaign aims to challenge the taboo of erectile dysfunction (ED) and encourage men, and their partners, to seek medical advice. There is a wide range of treatments available so men shouldn’t be afraid of consulting their GP or nurse to discuss the different options and ultimately find the treatment that best suits them.
For more information, please contact Red Door Communications:
Elie Newton 020 8392 8051 / firstname.lastname@example.org
Lizzie Lockett 020 8392 8063 / email@example.com
1.ICM. Men At Work National Survey, Commissioned by Bayer Schering Pharma, April 2008
2.Sexual Dysfunction Association - The Andropause and Testosterone Factsheet www.impotence.org.uk/downloads/Testosterone.pdf (Accessed May 2008)
3.ICM. ED Patient Research. Attitudes Towards Erectile Dysfunction (ED) and Treatment. Commissioned by Bayer Schering Pharma, May 2007
4.Bayer Schering Pharma Levitra ® SmPC, updated April 2008
5.Pfizer Limited Viagra® SmPC, updated March 2008
6.Eli Lilly and Company Limited Cialis® SmPC, updated March 2008
7.Hackett G et al. British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction. J Sex Med 2008 (In Press)
8.Feldman HA et al. Impotence and its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61
9.Sexual Dysfunction Association - Impotence or Erectile Dysfunction Factsheet.
www.sda.uk.net/downloads/Impotence_or_erectile_dysfunction.p... (Accessed May 2008)
This press release was distributed by ResponseSource Press Release Wire on behalf of Health Unlimited (Red Door Communications) in the following categories: Men's Interest, Health, Women's Interest & Beauty, Medical & Pharmaceutical, for more information visit https://pressreleasewire.responsesource.com/about.